Table S2 from Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

Authors:
  • JMJoana Murad
    Joana Murad
  • LWLillian Werner
    Lillian Werner
  • HDHeather Daley
    Heather Daley
  • HTHelene Trebeden-Negre
    Helene Trebeden-Negre
  • JGJoanina K. Gicobi
    Joanina K. Gicobi
  • ASAdam Schmucker
    Adam Schmucker
  • CSCharles L. Sentman
    Charles L. Sentman
  • DGDavid E. Gilham
    David E. Gilham
  • FLFrédéric F. Lehmann
    Frédéric F. Lehmann
  • IGIlene Galinsky
    Ilene Galinsky

Abstract
No abstract available